Skip to main content
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1979 Mar;54(3):204–207. doi: 10.1136/adc.54.3.204

A controlled trial of cyclophosphamide and azathioprine in Nigerian children with the nephrotic syndrome and poorly selective proteinuria.

A Adeniyi, R G Hendrickse, J F Soothill
PMCID: PMC1545245  PMID: 373645

Abstract

In a controlled trial, symptomatic treatment alone, or 12 weeks of cyclophosphamide or azathioprine were compared in Nigerian children with nephrotic syndrome (mainly quartan malarial nephropathy) and poorly selective proteinuria. Full remission in 2 patients in each of the two groups treated with drugs, and diminution of proteinuria in most patients in the cyclophosphamide group showed possible evidence of benefit. Infections during treatment were significantly more common in the drug-treated groups but were controllable. Mortality from renal failure in the 2nd year after treatment was significantly greater in the azathioprine-treated group than in the other two, suggesting that the drug may have exacerbated the nephritis. The 5-year survival rate was similar in the cyclophosphamide and the control group.

Full text

PDF
206

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adeniyi A., Hendrickse R. G., Houba V. Selectivity of proteinuria and response to prednisolone or immunosuppressive drugs in children with malarial nephrosis. Lancet. 1970 Mar 28;1(7648):644–648. doi: 10.1016/s0140-6736(70)90885-8. [DOI] [PubMed] [Google Scholar]
  2. Adeniyi A., Hendrickse R. G., Soothill J. F. Differential protein clearances and response to treatment in Nigerian nephrotic children. Arch Dis Child. 1976 Sep;51(9):691–696. doi: 10.1136/adc.51.9.691. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. HENDRICKSE R. G., GILLES H. M. The nephrotic syndrome and other renal diseases in children in Western Nigeria. East Afr Med J. 1963 May;40:186–201. [PubMed] [Google Scholar]
  4. Hendrickse R. G., Adeniyi A., Edington G. M., Glasgow E. F., White R. H., Houba V. Quartan malarial nephrotic syndrome. Collaborative clinicopathological study in Nigerian children. Lancet. 1972 May 27;1(7761):1143–1149. doi: 10.1016/s0140-6736(72)91373-6. [DOI] [PubMed] [Google Scholar]
  5. Kibukamusoke J. W. Malaria prophylaxis and immunosuppressant therapy in management of nephrotic syndrome associated with quartan malaria. Arch Dis Child. 1968 Oct;43(231):598–600. doi: 10.1136/adc.43.231.598. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Soothill J. F., Steward M. W. The immunopathological significance of the heterogeneity of antibody affinity. Clin Exp Immunol. 1971 Aug;9(2):193–199. [PMC free article] [PubMed] [Google Scholar]
  7. Steward M. W., Alpers J. H., Soothill J. F. The effect of cyclophosphamide on the antibody response. Proc R Soc Med. 1973 Aug;66(8):808–810. [PMC free article] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES